Hepatitis C virus infection: a current review.
Senecal
Douglas L
DL
Department of Hepatology, University of Florida College of Medicine, Gainesville, USA.
Morelli
Joseph
J
D000208:Acute Disease; D000998:Antiviral Agents / Q000627:therapeutic use; D002908:Chronic Disease; D005838:Genotype; D006526:Hepatitis C / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D011092:Polyethylene Glycols / Q000627:therapeutic use; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use; D018570:Risk Assessment; D012307:Risk Factors
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a